<SEC-DOCUMENT>0001157523-22-000799.txt : 20220624
<SEC-HEADER>0001157523-22-000799.hdr.sgml : 20220624
<ACCEPTANCE-DATETIME>20220624134126
ACCESSION NUMBER:		0001157523-22-000799
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20220623
FILED AS OF DATE:		20220624
DATE AS OF CHANGE:		20220624

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANIGRAM HOLDINGS INC.
		CENTRAL INDEX KEY:			0001620737
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38885
		FILM NUMBER:		221039278

	BUSINESS ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3
		BUSINESS PHONE:		506-384-1571

	MAIL ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORGANIGRAM HOLDINGS INC
		DATE OF NAME CHANGE:	20140926
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a52760763.htm
<DESCRIPTION>ORGANIGRAM HOLDINGS INC. 6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.3.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">UNITED STATES<br>
      SECURITIES AND EXCHANGE COMMISSION<br>
      <font style="font-size: 14pt;">Washington, D.C.&#160; 20549</font></div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">FORM 6-K</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div>&#160;</div>
    <div style="text-align: center;">For the month of <font style="font-weight: bold;">June 2022</font></div>
    <div>&#160;</div>
    <div style="text-align: center;">Commission File No. <font style="font-weight: bold;">001-38885</font></div>
    <div>&#160;</div>
    <div style="text-align: center;"><font style="font-size: 16pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>ORGANIGRAM HOLDINGS INC.</u></font><br>
      (Translation of registrant's name into English)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">35 English Drive<br>
      <u>Moncton, New Brunswick, Canada E1E 3X3</u></div>
    <div style="text-align: center;">(Address of principal executive office)</div>
    <div>&#160;</div>
    <div>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40&#8209;F</div>
    <div>&#160;</div>
    <div style="text-align: center;">Form 20-F&#160;&#160;<font style="font-weight: bold;">[&#160; ]</font>&#160; <font style="font-weight: bold;">Form 40-F&#160;&#160;[X]</font></div>
    <div>&#160;</div>
    <div>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) &#160;[&#160; ]</div>
    <div>&#160;</div>
    <div>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) &#160;[&#160; ]</div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">SUBMITTED HEREWITH</div>
    <div>&#160;</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zfa5aaa8c009f480c98556d907acf66a1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 9.82%; vertical-align: top;">
            <div style="margin-left: 5.4pt; font-weight: bold;"><u>Exhibits</u></div>
          </td>
          <td style="width: 90.18%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.82%; vertical-align: top;">
            <div style="margin-left: 5.4pt;"><a href="a52760763ex99_1.htm">99.1</a></div>
          </td>
          <td style="width: 90.18%; vertical-align: top;">
            <div style="margin-left: 2.6pt;"><a href="a52760763ex99_1.htm">News release dated
                June 23, 2022</a></div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
    <div style="page-break-after: always;" id="DSPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div><br>
    <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
    <div>&#160;</div>
    <div style="text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
      undersigned, thereunto duly authorized.</div>
    <div>&#160;</div>
    <div style="font-weight: bold;">ORGANIGRAM HOLDINGS INC.</div>
    <div>&#160;</div>
    <div><br>
      <br>
      <font style="font-style: italic;">/s/ Derrick West</font><br>
      ______________________________________<br>
      Derrick West<br>
      Chief Financial Officer</div>
    <div>&#160;</div>
    <div>Date:&#160; June 23, 2022</div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a52760763ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 8.3.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <table cellspacing="0" cellpadding="0" border="0" id="z0d5ebd9046164ad59cd83d12a92cafd5" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 50.00%;">
            <div>&#160;</div>
          </td>
          <td style="width: 50.00%;">
            <div style="text-align: right;">&#160;<font style="font-weight: bold;">Exhibit 99.1</font></div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div>
      <div class="bw-release">
        <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>Proposed Settlement Reached in 2016 Class Action</b> </h1>
        <div class="bw-release-body">
          <div class="bw-release-table-js bw-release-story">
            <p>TORONTO--(BUSINESS WIRE)--June 23, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), and its subsidiary Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis in Canada, has reached a
              proposed settlement (&#8220;Settlement&#8221;) in a previously disclosed class action related to medical cannabis that was voluntarily recalled in December 2016 and January 2017 (&#8220;Class Action&#8221;). The Supreme Court of Nova Scotia (the &#8220;Court&#8221;) approved
              notice of Settlement will be sent to class members beginning on June 24, 2022. </p>
            <p> As part the Settlement, the Company has agreed to pay an aggregate of $2,310,000 (the &#8220;Settlement Amount&#8221;), which amount has been previously accrued in the Company&#8217;s financial statements for the prior fiscal year. </p>
            <p> For the proposed Settlement to become effective, it must be approved by the Court. The Court must be satisfied that the settlement is fair, reasonable and in the best interest of the Class. On August 31, 2022, the Court will hold a hearing
              to consider whether to approve the Settlement. If the Settlement is approved by the Court, the Settlement Amount will be used to provide Class Members a refund of the amounts paid to purchase the voluntarily recalled product, less any refunds
              they have already received, as well as the payment of legal fees. In addition, the Company has agreed to pay the third-party claims administration costs. </p>
            <p> <b>About Organigram Holdings Inc.</b> </p>
            <p> Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada,
              and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused soft chews in Canada. </p>
            <p> Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company&#8217;s global footprint. Organigram has also developed and
              acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Big Bag O&#8217; Buds, SHRED, SHRED&#8217;ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New Brunswick and
              Lac-Sup&#233;rieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). </p>
            <div> </div>
            <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
              <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
                <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
            </div>
            <p> This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as &#8220;plans&#8221;, &#8220;expects&#8221;, &#8220;estimates&#8221;, &#8220;intends&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221; or variations of
              such words and phrases or state that certain actions, events, or results &#8220;may&#8221;, &#8220;could&#8221;, &#8220;would&#8221;, &#8220;might&#8221; or &#8220;will&#8221; be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors
              that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained
              in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such
              forward-looking information include factors and risks as disclosed in the Company&#8217;s most recent annual information form, management&#8217;s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and
              filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although
              the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such
              events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent
              required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. </p>
          </div>
          <div class="bw-release-contact">
            <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
            <p> <b>For media inquiries: </b><br>
              Paolo De Luca <br>
              Chief Strategy Officer <br>
              paolo.deluca@organigram.ca </p>
            <p> <b>For investor inquiries: </b><br>
              investors@organigram.ca </p>
          </div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
